Medical Condition News

RSS

Child sleep disorders on the rise due to social media and obesity

More and more children in England are being diagnosed with sleep problems, including nightmares, sleepwalking, and insomnia.

1 Oct 2018

Up to half of people with Alzheimer's disease use psychotropic drug, finds study

Up to half of people with Alzheimer's disease use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conducted at the University of Eastern Finland.

1 Oct 2018

Researchers investigate ability of Masimo ORi to reduce time ICU patients experience hyperoxemia

Masimo announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™ to help clinicians reduce the number of days ICU patients experience hyperoxemia while on mechanical ventilation.

1 Oct 2018

International conference features cutting-edge research studies on cancer immunotherapy

The Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, to be held in New York, Sept. 30-Oct. 3, will feature cutting-edge research studies from around the world that endeavor to answer urgent questions in the field of cancer immunotherapy to advance progress more rapidly for patients.

1 Oct 2018

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

The health care systems in some European countries lack the capacity to rapidly move a disease-modifying treatment for Alzheimer's disease from approval into widespread clinical use, which could leave 1 million people without access to transformative care if such a breakthrough occurs, according to a new RAND Corporation study.

1 Oct 2018

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

Angiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head, face, neck, or scalp, according to data presented at the fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.

1 Oct 2018

New insights into application of drug-eluting stents during percutaneous coronary intervention

Researchers at the Thorax Centrum Twente of Medisch Spectrum Twente and the University of Twente have recently completed their fourth major study into the application of drug-eluting stents during percutaneous coronary intervention.

1 Oct 2018

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.

30 Sep 2018

$Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors$

Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors

A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to data presented at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held Sept. 30-Oct. 3.

30 Sep 2018

Promising vaccine may provide new treatment option for patients with HER2-positive cancers

Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according to data from a phase I clinical trial presented at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held Sept. 30-Oct. 3.

30 Sep 2018

UB receives £1.78 million to find new therapies for treating heart failure and diabetes

The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.

29 Sep 2018

Researchers examine factors associated with mortality post- traumatic brain injury

Model system researchers have examined the factors associated with mortality among individuals aged 16 years and older who were more than one year post- traumatic brain injury.

29 Sep 2018

Cancer undercuts ability of normal cells to consume glucose, finds study

Cancer needs energy to drive its out-of-control growth. It gets energy in the form of glucose, in fact consuming so much glucose that one method for imaging cancer simply looks for areas of extreme glucose consumption - where there is consumption, there is cancer.

29 Sep 2018

Researchers design new combination therapy for reducing NSCLC cell growth

Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.

29 Sep 2018

Diabetes UK Professional Conference 2019 to take place at ACC Liverpool

Registration to the 21st edition of Diabetes UK’s Professional Conference is now open, with the conference set to take place from Wednesday 6 March to Friday 8 March of next year at the Arena and Convention Centre Liverpool.

29 Sep 2018

Ethicon demonstrates commitment to improve access to life-changing obesity treatment

Ethicon, part of Johnson & Johnson Medical Devices Companies, demonstrates its commitment to improving access to life-changing obesity treatment and putting the most appropriate surgical tools in surgeons hands at the 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic Diseases.

29 Sep 2018

Early Parkinson’s disease patients wait too long before seeking medical attention

The time between diagnosis and the institution of symptomatic treatment is critical in the effort to find a cure for Parkinson's Disease.

29 Sep 2018

SDSU receives $4M grant to boost number of Latino researchers studying Alzheimer's disease

The National Institute on Aging has awarded scientists at University of California San Diego School of Medicine and San Diego State University with a five-year, $4 million grant to boost the number of Latino and other underrepresented minority researchers studying Alzheimer's disease and related dementias afflicting seniors of Latino origins, a demographic historically overlooked.

29 Sep 2018

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.

28 Sep 2018

$GSA endorses Global Call to Action to improve care of people with fragility fractures$

GSA endorses Global Call to Action to improve care of people with fragility fractures

The Gerontological Society of America -- the nation's largest interdisciplinary organization devoted to the field of aging -- has signed on to the Fragility Fracture Network's Global Call to Action to improve the care of people with fragility fractures.

28 Sep 2018

Medical Condition News

Child sleep disorders on the rise due to social media and obesity

Up to half of people with Alzheimer's disease use psychotropic drug, finds study

Researchers investigate ability of Masimo ORi to reduce time ICU patients experience hyperoxemia

International conference features cutting-edge research studies on cancer immunotherapy

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

New insights into application of drug-eluting stents during percutaneous coronary intervention

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors

Promising vaccine may provide new treatment option for patients with HER2-positive cancers

UB receives £1.78 million to find new therapies for treating heart failure and diabetes

Researchers examine factors associated with mortality post- traumatic brain injury

Cancer undercuts ability of normal cells to consume glucose, finds study

Researchers design new combination therapy for reducing NSCLC cell growth

Diabetes UK Professional Conference 2019 to take place at ACC Liverpool

Ethicon demonstrates commitment to improve access to life-changing obesity treatment

Early Parkinson’s disease patients wait too long before seeking medical attention

SDSU receives $4M grant to boost number of Latino researchers studying Alzheimer's disease

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

GSA endorses Global Call to Action to improve care of people with fragility fractures

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News